Page 4 - Centric Services News Today

South & Central America witnessed a 9.2% rises in IT hiring activity in the pharma industry in March 2022, according to GlobalData’s Job Analytics index

Poland’s pharma industry registered a 2.1% rises in IT hiring activity in March 2022, according to GlobalData

The University of California (UC) San Diego in the US has joined a Phase II clinical trial to assess various Covid-19 booster vaccines.

Sage Therapeutics has reported data from the Phase II trial of SAGE-718 in individuals with MCI and mild dementia due to Alzheimer’s disease.

Akston Biosciences is set to commence a Phase II trial of its protein subunit Covid-19 vaccine, AKS-452, as a booster in the Netherlands.

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A sma...

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A sma...

Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A sma...

Lung Therapeutics has concluded the Phase Ia trial of its LTI-03 intended for the treatment of idiopathic pulmonary fibrosis (IPF).

The American Red Cross declares that there is a decrease in blood donations due to Covid-19 and blood drives should be re-established as SCD cases rise.